128 related articles for article (PubMed ID: 8580276)
1. The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease.
Breese EJ; Michie CA; Nicholls SW; Williams CB; Domizio P; Walker-Smith JA; MacDonald TT
Aliment Pharmacol Ther; 1995 Oct; 9(5):547-52. PubMed ID: 8580276
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa.
Breese E; Braegger CP; Corrigan CJ; Walker-Smith JA; MacDonald TT
Immunology; 1993 Jan; 78(1):127-31. PubMed ID: 8436398
[TBL] [Abstract][Full Text] [Related]
3. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
4. Decreased mucosal interleukin-4 (IL-4) production in gut inflammation.
Karttunnen R; Breese EJ; Walker-Smith JA; MacDonald TT
J Clin Pathol; 1994 Nov; 47(11):1015-8. PubMed ID: 7829675
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease.
Breese EJ; Michie CA; Nicholls SW; Murch SH; Williams CB; Domizio P; Walker-Smith JA; MacDonald TT
Gastroenterology; 1994 Jun; 106(6):1455-66. PubMed ID: 8194690
[TBL] [Abstract][Full Text] [Related]
6. Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn's disease.
Stallmach A; Giese T; Schmidt C; Ludwig B; Mueller-Molaian I; Meuer SC
Int J Colorectal Dis; 2004 Jul; 19(4):308-15. PubMed ID: 14605835
[TBL] [Abstract][Full Text] [Related]
7. Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone.
Azcue M; Rashid M; Griffiths A; Pencharz PB
Gut; 1997 Aug; 41(2):203-8. PubMed ID: 9301499
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin as initial treatment for Crohn's disease.
Nicholls S; Domizio P; Williams CB; Dawnay A; Braegger CP; MacDonald TT; Walker-Smith JA
Arch Dis Child; 1994 Sep; 71(3):243-7. PubMed ID: 7979499
[TBL] [Abstract][Full Text] [Related]
9. Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls.
Kusugami K; Youngman KR; West GA; Fiocchi C
Gastroenterology; 1989 Jul; 97(1):1-9. PubMed ID: 2785943
[TBL] [Abstract][Full Text] [Related]
10. Diversion of intestinal flow decreases the numbers of interleukin 4 secreting and interferon gamma secreting T lymphocytes in small bowel mucosa.
Schmit A; Van Gossum A; Carol M; Houben JJ; Mascart F
Gut; 2000 Jan; 46(1):40-5. PubMed ID: 10601053
[TBL] [Abstract][Full Text] [Related]
11. Suppressive effects of cyclosporine A on neutrophils and T cells may be related to therapeutic benefits in patients with steroid-resistant ulcerative colitis.
Ina K; Kusugami K; Shimada M; Tsuzuki T; Nishio Y; Binion DG; Imada A; Ando T
Inflamm Bowel Dis; 2002 Jan; 8(1):1-9. PubMed ID: 11837932
[TBL] [Abstract][Full Text] [Related]
12. In situ activated intestinal T cells expanded in vitro--without addition of antigen--produce IFN-gamma and IL-10 and preserve their function during growth.
Agnholt J; Kaltoft K
Exp Clin Immunogenet; 2001; 18(4):213-25. PubMed ID: 11872952
[TBL] [Abstract][Full Text] [Related]
13. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
[TBL] [Abstract][Full Text] [Related]
14. Clinical response does not correlate with intestinal or blood cyclosporine concentrations in patients with Crohn's disease treated with high-dose oral cyclosporine.
Sandborn WJ; Tremaine WJ; Lawson GM
Am J Gastroenterol; 1996 Jan; 91(1):37-43. PubMed ID: 8561141
[TBL] [Abstract][Full Text] [Related]
15. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
[TBL] [Abstract][Full Text] [Related]
16. Expression of HLA-DR antigens in inflammatory bowel disease mucosa: role of intestinal lamina propria mononuclear cell-derived interferon gamma.
Qin OY; el-Youssef M; Yen-Lieberman B; Sapatnekar W; Youngman KR; Kusugami K; Fiocchi C
Dig Dis Sci; 1988 Dec; 33(12):1528-36. PubMed ID: 3143537
[TBL] [Abstract][Full Text] [Related]
17. Crohn's disease intestinal CD4+ T cells have impaired interleukin-10 production which is not restored by probiotic bacteria.
Hvas CL; Kelsen J; Agnholt J; Höllsberg P; Tvede M; Møller JK; Dahlerup JF
Scand J Gastroenterol; 2007 May; 42(5):592-601. PubMed ID: 17454880
[TBL] [Abstract][Full Text] [Related]
18. Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis.
Mullin GE; Lazenby AJ; Harris ML; Bayless TM; James SP
Gastroenterology; 1992 May; 102(5):1620-7. PubMed ID: 1568572
[TBL] [Abstract][Full Text] [Related]
19. Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's disease.
Schmitt H; Billmeier U; Dieterich W; Rath T; Sonnewald S; Reid S; Hirschmann S; Hildner K; Waldner MJ; Mudter J; Hartmann A; Grützmann R; Neufert C; Münster T; Neurath MF; Atreya R
Gut; 2019 May; 68(5):814-828. PubMed ID: 29848778
[TBL] [Abstract][Full Text] [Related]
20. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
Tang R; Yang G; Zhang S; Wu C; Chen M
Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
